Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

Completed · Phase 2 · Has a placebo group

Conditions studied: Adult ADHD

In brief

The purpose of this study is to determine whether 2 weeks of treatment with AZD1446 compared to placebo improves ADHD symptoms and is well tolerated.

Key facts

Study ID

NCT01012375

Run by

AstraZeneca

People needed

135

Starts

2009-11-01

Expected to finish

2010-08-01

Last updated by the study team

2011-09-02

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A confirmed diagnosis of ADHD
• Patient understands and is willing to comply with all study requirements
• Adults between the ages of 18-65 inclusive

You may not qualify if…

• Current psychiatric disorder other than ADHD
• Previous randomization into this study
• Women with a positive pregnancy test

Where it is running

• Research Site — Los Alamitos, California, United States
• Research Site — Fort Myers, Florida, United States
• Research Site — New York, New York, United States
• Research Site — Austin, Texas, United States
• Research Site — Burlington, Vermont, United States
• Research Site — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.